ResearcherJiaxing UniversityActive in the last 2 years

Shaohan Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0559-7155; OpenAlex author ID A5101795873. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

DDX21 functions as a potential novel oncopromoter in pancreatic ductal adenocarcinoma: a comprehensive analysis of the DExD box family. Co-author DOI 10.1007/s12672-024-01204-9 ↗
CircZFR promotes pancreatic cancer progression through a novel circRNA-miRNA-mRNA pathway and stabilizing epithelial-mesenchymal transition protein. Co-author DOI 10.1016/j.cellsig.2023.110661 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Lei Qin · 1 shared paper, 2024 · strength 0.28
- Paper DDX21 functions as a potential novel oncopromoter in pancreatic ductal adenocarcinoma: a comprehensive analysis of the … DOI 10.1007/s12672-024-01204-9 ↗
Jing Wang · 1 shared paper, 2023 · strength 0.18
- Paper CircZFR promotes pancreatic cancer progression through a novel circRNA-miRNA-mRNA pathway and stabilizing epithelial-me… DOI 10.1016/j.cellsig.2023.110661 ↗
Zhongcheng Zhou · 1 shared paper, 2023 · strength 0.18
- Paper CircZFR promotes pancreatic cancer progression through a novel circRNA-miRNA-mRNA pathway and stabilizing epithelial-me… DOI 10.1016/j.cellsig.2023.110661 ↗
Yiyu Shen · 1 shared paper, 2023 · strength 0.18
- Paper CircZFR promotes pancreatic cancer progression through a novel circRNA-miRNA-mRNA pathway and stabilizing epithelial-me… DOI 10.1016/j.cellsig.2023.110661 ↗
Bin Wu · 1 shared paper, 2023 · strength 0.18
- Paper CircZFR promotes pancreatic cancer progression through a novel circRNA-miRNA-mRNA pathway and stabilizing epithelial-me… DOI 10.1016/j.cellsig.2023.110661 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.